SCHEMBL5599372

SCHEMBL5599372

CN(C)C(Cl)COc1ccc(Cc2ccnn2C)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP19A1 P11511 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
LTA4H P09960 4/20 0.34
TAS1R3 Q7RTX0 1/20 0.33
TAS1R1 Q7RTX1 1/20 0.33
TAS1R2 Q8TE23 1/20 0.33
LMNA P02545 3/20 0.32
KCNH2 Q12809 2/20 0.30
HRH3 Q9Y5N1 2/20 0.30
SMN1; SMN2 Q16637 2/20 0.30
MEN1 O00255 2/20 0.30
KMT2A Q03164 2/20 0.30
MAPT P10636 1/20 0.30
MAPK1 P28482 1/20 0.30
HTT P42858 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5599334 0.78 ADRB2 (0.35)
SCHEMBL7755878 0.77 LTA4H (0.56) CYP1A2CYP3A4CYP2D6CYP19A1CYP2C9
SCHEMBL5601407 0.77 MEN1 (0.44) LTA4HLMNASMN1; SMN2MEN1KMT2A
SCHEMBL21000906 0.74 LTA4H (0.47) CYP2D6LTA4HLMNASMN1; SMN2MAPK1
SCHEMBL6654256 0.69 MEN1 (0.33) MEN1KMT2A
SCHEMBL16877234 0.68 RAB9A (0.41) CYP19A1KCNH2SMN1; SMN2KMT2AL3MBTL1
SCHEMBL332470 0.68 DRD4 (0.40) CYP19A1KCNH2HRH3KMT2AL3MBTL1
SCHEMBL7757122 0.67 KDM5A (0.43) CYP19A1LMNAKCNH2SMN1; SMN2KMT2A
SCHEMBL5599079 0.65 KMT2A (0.42) LTA4HLMNASMN1; SMN2MEN1KMT2A
SCHEMBL5599111 0.65 GAA (0.38) LTA4HLMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1103243-B1 UTILIZATION OF ARYL(OR HETEROARYL)AZOLYLCARBINOL DERIVATIVES FOR THE TREATMENT OF TROUBLES MEDIATED BY AN EXCESS OF SUBSTANCE P ESTEVE LABOR DR (ES) 2004-01-07 EP claimed
EP-1755678-A2 ACTIVE SUBSTANCE COMBINATION OF A CARBINOL COMPOUND AND AN OPIOID LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2007-02-28 EP disclosed
WO-2005097192-A2 ACTIVE SUBSTANCE COMBINATION OF A CARBINOL COMPOUND AND AN OPIOID LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2005-10-20 WO disclosed